Comparison Overview

Biotron Laboratories, Inc. (now Actylis)

VS

INEOS

Biotron Laboratories, Inc. (now Actylis)

750 North 120 West, Centerville, 84014, US
Last Update: 2026-04-03
View Profile
Between 750 and 799
https://www.actylis.com

Actylis was created from the merger of eight experienced specialty manufacturing companies and three sourcing firms, integrated into a single entity. Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and AgriScience industries. Actylis' Nutrition division specializes in manufacturing mineral amino acid chelates and complexes. Our goal is to provide our corporate customers top-tier service and continual product improvement resulting in premium materials. To accomplish these goals, we rely on a depth of experience, a rigorous approach to product quality and emphasize both scientific validation and integrity.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 18
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

INEOS

38 Hans Crescent, London, SW1X 0LZ, GB
Last Update: 2026-04-01
Between 750 and 799
http://www.ineos.com

We are a global manufacturer of raw materials and a producer of energy used in everyday life. From medicines to mobile phones, agriculture to automotive, our products enhance standards of living for everyone around the world. We understand the challenge the world is facing, and we are working hard to help economies, businesses and individuals deliver a zero carbon emissions future to meet the commitments of the Paris Agreement. Our plans and actions revolve around implementing carbon emission reduction, making safe and sustainable products, investing in the energy transition, all while creating jobs, improving living standards worldwide. But we wouldn't be able to achieve any of these without our 26,000 dedicated and talented colleagues. It is why we celebrate and reward individuals and teams who strive to push boundaries to constantly innovate and find new and better ways of doing things.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 12,126
Subsidiaries: 22
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/ineos.jpeg
INEOS
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Biotron Laboratories, Inc. (now Actylis)
100%
Compliance Rate
0/4 Standards Verified
INEOS
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Chemical Manufacturing Industry Average (This Year)

No incidents recorded for Biotron Laboratories, Inc. (now Actylis) in 2026.

Incidents vs Chemical Manufacturing Industry Average (This Year)

No incidents recorded for INEOS in 2026.

Incident History — Biotron Laboratories, Inc. (now Actylis) (X = Date, Y = Severity)

Biotron Laboratories, Inc. (now Actylis) cyber incidents detection timeline including parent company and subsidiaries

Incident History — INEOS (X = Date, Y = Severity)

INEOS cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
Incidents

No Incident

https://images.rankiteo.com/companyimages/ineos.jpeg
INEOS
Incidents

No Incident

FAQ

INEOS company demonstrates a stronger AI Cybersecurity Score compared to Biotron Laboratories, Inc. (now Actylis) company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, INEOS company has disclosed a higher number of cyber incidents compared to Biotron Laboratories, Inc. (now Actylis) company.

In the current year, INEOS company and Biotron Laboratories, Inc. (now Actylis) company have not reported any cyber incidents.

Neither INEOS company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing a ransomware attack publicly.

Neither INEOS company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing a data breach publicly.

Neither INEOS company nor Biotron Laboratories, Inc. (now Actylis) company has reported experiencing targeted cyberattacks publicly.

Neither Biotron Laboratories, Inc. (now Actylis) company nor INEOS company has reported experiencing or disclosing vulnerabilities publicly.

Neither Biotron Laboratories, Inc. (now Actylis) nor INEOS holds any compliance certifications.

Neither company holds any compliance certifications.

INEOS company has more subsidiaries worldwide compared to Biotron Laboratories, Inc. (now Actylis) company.

INEOS company employs more people globally than Biotron Laboratories, Inc. (now Actylis) company, reflecting its scale as a Chemical Manufacturing.

Neither Biotron Laboratories, Inc. (now Actylis) nor INEOS holds SOC 2 Type 1 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor INEOS holds SOC 2 Type 2 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor INEOS holds ISO 27001 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor INEOS holds PCI DSS certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor INEOS holds HIPAA certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor INEOS holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Published
Date
2026-04-02
Updated
Date
2026-04-02
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References